BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
15 hedge funds and large institutions have $1.04M invested in Better Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
5
Reduced
3
Closed
2
Calls
$84K
Puts
–
Net Calls
+$84K
Net Calls Change
-$85K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$19K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2.77K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$307K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$6K |
| 5 |
5
BlackRock
New York
|
$56.8K |
